Skip to content

The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis

The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00509314
Enrollment
400
Registered
2007-07-31
Start date
2006-05-31
Completion date
2016-12-31
Last updated
2007-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanocyte, Vitiligo

Brief summary

The aim of this study is to survey melanocytes in the ability of self-assembly on biomaterials and functional analysis in vitro. Also, this study may provide a better way for treatment of vitiligo after understanding the functional aspects of melanocytes.

Detailed description

Vitiligo is a chronic disease that causes loss of melanocyte and pigment of the skin. Traditional treatments for vitiligo including topical corticosteroids and phototherapy lead to limited clinical effects. Autologous melanocyte transplantation is another way to treat vitiligo. However, the effect is largely affected by whether cultivated melanocytes are successfully uptaken by vitiliginous skin. The aim of this study is to survey the self-assembly on biomaterials and functional analysis. In the long run, this study may provide a better way for treatment of vitiligo.

Interventions

BEHAVIORALmelanocyte self-assembly and functional analysis

Sponsors

National Science and Technology Council, Taiwan
CollaboratorOTHER_GOV
National Health Research Institutes, Taiwan
CollaboratorOTHER
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
NATURAL_HISTORY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients receiving cosmetic removal of moles

Exclusion criteria

* No special

Countries

Taiwan

Contacts

Primary ContactSung-Jan Lin, MD PhD
jsjl2000tw@yahoo.com.tw+886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026